186 related articles for article (PubMed ID: 26158899)
1. Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines.
Hanavan PD; Borges CR; Katchman BA; Faigel DO; Ho TH; Ma CT; Sergienko EA; Meurice N; Petit JL; Lake DF
Oncotarget; 2015 Jul; 6(21):18418-28. PubMed ID: 26158899
[TBL] [Abstract][Full Text] [Related]
2. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
3. Molecular Inhibitor of QSOX1 Suppresses Tumor Growth
Fifield AL; Hanavan PD; Faigel DO; Sergienko E; Bobkov A; Meurice N; Petit JL; Polito A; Caulfield TR; Castle EP; Copland JA; Mukhopadhyay D; Pal K; Dutta SK; Luo H; Ho TH; Lake DF
Mol Cancer Ther; 2020 Jan; 19(1):112-122. PubMed ID: 31575656
[TBL] [Abstract][Full Text] [Related]
4. HIF1 contributes to hypoxia-induced pancreatic cancer cells invasion via promoting QSOX1 expression.
Shi CY; Fan Y; Liu B; Lou WH
Cell Physiol Biochem; 2013; 32(3):561-8. PubMed ID: 24008827
[TBL] [Abstract][Full Text] [Related]
5. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
6. An inhibitory antibody blocks the first step in the dithiol/disulfide relay mechanism of the enzyme QSOX1.
Grossman I; Alon A; Ilani T; Fass D
J Mol Biol; 2013 Nov; 425(22):4366-78. PubMed ID: 23867277
[TBL] [Abstract][Full Text] [Related]
7. High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.
Pernodet N; Hermetet F; Adami P; Vejux A; Descotes F; Borg C; Adams M; Pallandre JR; Viennet G; Esnard F; Jouvenot M; Despouy G
Breast Cancer Res; 2012 Oct; 14(5):R136. PubMed ID: 23098186
[TBL] [Abstract][Full Text] [Related]
8. A secreted disulfide catalyst controls extracellular matrix composition and function.
Ilani T; Alon A; Grossman I; Horowitz B; Kartvelishvily E; Cohen SR; Fass D
Science; 2013 Jul; 341(6141):74-6. PubMed ID: 23704371
[TBL] [Abstract][Full Text] [Related]
9. QSOX1 inhibits autophagic flux in breast cancer cells.
Poillet L; Pernodet N; Boyer-Guittaut M; Adami P; Borg C; Jouvenot M; Delage-Mourroux R; Despouy G
PLoS One; 2014; 9(1):e86641. PubMed ID: 24475161
[TBL] [Abstract][Full Text] [Related]
10. cis-Proline mutants of quiescin sulfhydryl oxidase 1 with altered redox properties undermine extracellular matrix integrity and cell adhesion in fibroblast cultures.
Javitt G; Grossman-Haham I; Alon A; Resnick E; Mutsafi Y; Ilani T; Fass D
Protein Sci; 2019 Jan; 28(1):228-238. PubMed ID: 30367560
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits renal cell carcinoma cell proliferation.
Meng S; Zhu Y; Li JF; Wang X; Liang Z; Li SQ; Xu X; Chen H; Liu B; Zheng XY; Xie LP
Oncotarget; 2017 Mar; 8(12):19834-19842. PubMed ID: 28423637
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
13. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
Jung CH; Washburn MP; Wells WW
Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
[TBL] [Abstract][Full Text] [Related]
14. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
15. G Protein Alpha S Subunit Promotes Cell Proliferation of Renal Cell Carcinoma with Involvement of Protein Kinase A Signaling.
Zhang B; Sun N; Mu X; Zhi L; Zhai L; Jiang Y; Fu Z; Yao Z
DNA Cell Biol; 2017 Mar; 36(3):237-242. PubMed ID: 28051330
[TBL] [Abstract][Full Text] [Related]
16. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition of zinc-finger transcription factors by selenium compounds ebselen and selenite.
Larabee JL; Hocker JR; Hanas JS
J Inorg Biochem; 2009 Mar; 103(3):419-26. PubMed ID: 19167089
[TBL] [Abstract][Full Text] [Related]
18. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
19. The reaction of ebselen with peroxynitrite.
Masumoto H; Sies H
Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
[TBL] [Abstract][Full Text] [Related]
20. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]